blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1838867

EP1838867 - APOLIPOPROTEIN A-II ISOFORM AS A BIOMARKER FOR PROSTATE CANCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.01.2012
Database last updated on 05.08.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Eastern Virginia Medical School
825 Fairfax Avenue P.O.Box 1980
Norfolk, VA 23507 / US
[2010/36]
Former [2007/40]For all designated states
Eastern Virginia Medical School
825 Fairfax Avenue, P.O. Box 1980
Norfolk, VA 23501-6006 / US
Inventor(s)01 / SEMMES, John, O.
207 James River Drive
Newport News, VA 23601 / US
02 / MALIK, Gunjan
16111 La Madera Rio
Helotes, TX 78023 / US
03 / WARD, Michael, D.
1302 Equinox Landing
Chesapeake, VA 23322 / US
 [2007/52]
Former [2007/40]01 / SEMMES, John, O.
207 James River Drive
Newport News, VA 23601 / US
02 / MALIK, Gunjan
417-B Oak Lake Way
Chesapeake, VA 23320 / US
03 / WARD, Michael, D.
1302 Equinox Landing
Chesapeake, VA 23322 / US
Representative(s)Lee, Nicholas John, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2007/40]Lee, Nicholas John, et al
Kilburn & Strode 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date06717624.806.01.2006
[2007/40]
WO2006US00450
Priority number, dateUS20050642332P06.01.2005         Original published format: US 642332 P
[2007/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006074360
Date:13.07.2006
Language:EN
[2006/28]
Type: A2 Application without search report 
No.:EP1838867
Date:03.10.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 13.07.2006 takes the place of the publication of the European patent application.
[2007/40]
Type: B1 Patent specification 
No.:EP1838867
Date:09.03.2011
Language:EN
[2011/10]
Search report(s)International search report - published on:US11.01.2007
(Supplementary) European search report - dispatched on:EP30.01.2009
ClassificationIPC:C12Q1/00, G01N33/53
[2007/40]
CPC:
G01N33/57434 (EP,US); G01N33/92 (EP,US); G01N2333/775 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/40]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:APOLIPOPROTEIN-A-II-ISOFORM ALS BIOMARKER FÜR PROSTATAKREBS[2007/40]
English:APOLIPOPROTEIN A-II ISOFORM AS A BIOMARKER FOR PROSTATE CANCER[2007/40]
French:ISOFORME D'APOLIPOPROTEINE A-II UTILISEE EN TANT QUE BIOMARQUEUR POUR LE CANCER DE LA PROSTATE[2007/40]
Entry into regional phase06.08.2007National basic fee paid 
06.08.2007Search fee paid 
06.08.2007Designation fee(s) paid 
06.08.2007Examination fee paid 
Examination procedure06.08.2007Examination requested  [2007/40]
05.09.2007Amendment by applicant (claims and/or description)
03.06.2009Despatch of a communication from the examining division (Time limit: M04)
30.09.2009Reply to a communication from the examining division
10.03.2010Despatch of a communication from the examining division (Time limit: M04)
14.06.2010Reply to a communication from the examining division
20.08.2010Communication of intention to grant the patent
10.11.2010Fee for grant paid
10.11.2010Fee for publishing/printing paid
Opposition(s)12.12.2011No opposition filed within time limit [2012/07]
Fees paidRenewal fee
25.01.2008Renewal fee patent year 03
30.01.2009Renewal fee patent year 04
25.01.2010Renewal fee patent year 05
25.01.2011Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.01.2006
AT09.03.2011
BE09.03.2011
CY09.03.2011
CZ09.03.2011
DK09.03.2011
EE09.03.2011
FI09.03.2011
LT09.03.2011
LV09.03.2011
PL09.03.2011
RO09.03.2011
SI09.03.2011
SK09.03.2011
TR09.03.2011
BG09.06.2011
GR10.06.2011
ES20.06.2011
IS09.07.2011
PT11.07.2011
[2014/34]
Former [2014/21]AT09.03.2011
BE09.03.2011
CY09.03.2011
CZ09.03.2011
DK09.03.2011
EE09.03.2011
FI09.03.2011
LT09.03.2011
LV09.03.2011
PL09.03.2011
RO09.03.2011
SI09.03.2011
SK09.03.2011
TR09.03.2011
BG09.06.2011
GR10.06.2011
ES20.06.2011
IS09.07.2011
PT11.07.2011
Former [2012/11]AT09.03.2011
BE09.03.2011
CY09.03.2011
CZ09.03.2011
DK09.03.2011
EE09.03.2011
FI09.03.2011
LT09.03.2011
LV09.03.2011
PL09.03.2011
RO09.03.2011
SI09.03.2011
SK09.03.2011
BG09.06.2011
GR10.06.2011
ES20.06.2011
IS09.07.2011
PT11.07.2011
Former [2012/10]AT09.03.2011
BE09.03.2011
CY09.03.2011
CZ09.03.2011
DK09.03.2011
EE09.03.2011
FI09.03.2011
LT09.03.2011
LV09.03.2011
RO09.03.2011
SI09.03.2011
SK09.03.2011
BG09.06.2011
GR10.06.2011
ES20.06.2011
IS09.07.2011
PT11.07.2011
Former [2011/50]AT09.03.2011
BE09.03.2011
CY09.03.2011
CZ09.03.2011
EE09.03.2011
FI09.03.2011
LT09.03.2011
LV09.03.2011
RO09.03.2011
SI09.03.2011
SK09.03.2011
BG09.06.2011
GR10.06.2011
ES20.06.2011
IS09.07.2011
PT11.07.2011
PL20.07.2011
Former [2011/47]AT09.03.2011
BE09.03.2011
CY09.03.2011
EE09.03.2011
FI09.03.2011
LT09.03.2011
LV09.03.2011
SI09.03.2011
BG09.06.2011
GR10.06.2011
ES20.06.2011
PT11.07.2011
Former [2011/41]AT09.03.2011
BE09.03.2011
CY09.03.2011
FI09.03.2011
LT09.03.2011
LV09.03.2011
SI09.03.2011
BG09.06.2011
GR10.06.2011
ES20.06.2011
Former [2011/39]AT09.03.2011
CY09.03.2011
FI09.03.2011
LT09.03.2011
LV09.03.2011
SI09.03.2011
BG09.06.2011
GR10.06.2011
ES20.06.2011
Former [2011/37]CY09.03.2011
FI09.03.2011
LT09.03.2011
LV09.03.2011
SI09.03.2011
BG09.06.2011
GR10.06.2011
ES20.06.2011
Former [2011/36]LT09.03.2011
LV09.03.2011
GR10.06.2011
ES20.06.2011
Documents cited:Search[X]EP1300683  (INT REAGENTS CORP [JP]) [X] 17-20,24* the whole document *
International search[A]  - NIEDERKOFLER ET AL., "Novel Mass Spectrometric Immunoassays for the Rapid Structural Characterization of Plasma Apolipoproteins", J. LIPID RES., (200303), vol. 44, no. 3, pages 630 - 639, XP009013322

DOI:   http://dx.doi.org/10.1194/jlr.D200034-JLR200
 [XP]  - MALIK ET AL., "Serum Levels of an Isoform of Apolipoprotein A-II as a Potential Marker for Prostate Cancer", CLIN. CANCER RES., (20050201), vol. 11, no. 3, pages 1073 - 1085, XP003005157
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.